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Abstract. The Kfgf gene, which encodes a member of
the fibroblast growth factor family, was originally dis-
covered by assaying human tumor DNA for
dominantly transforming oncogenes. The 22-kD kFGF
product contains a single site for asparagine-linked
glycosylation and an amino-terminal signal peptide for
vectorial synthesis into the endoplasmic reticulum and
eventual secretion. To determine whether these fea-
tures are necessary for transformation, we have con-
structed mutants of kFGF that are impaired for
glycosylation or secretion. All mutants retained the
ability to induce DNA synthesis when added to quies-
HEKfgfgene, referred to in the literatureas Hst, Hst-1,
HSM, FGFK, and KS3, was identified as a trans-
forming gene after transfection of human tumor DNA
into mouse NIH3T3 fibroblasts (10, 44). The profusion of
names stems in part from its simultaneous discovery in
different laboratories, using DNA from a variety of human
tumors, including stomach cancer, Kaposi's sarcoma, mela-
noma, colon carcinoma, and hepatoma (3, 10, 29, 36, 44) .
However, there are no indications that Kfgf played any role
in the genesis of these tumors since the same gene isolated
from normal human DNA is also capable of eliciting mor-
phological transformation of transfected NIH3T3 cells (45) .
The transforming activity is therefore assumed to reflect
transcriptional activation of the gene during transfection. In
contrast, the mouse homologue of the gene has been impli-
cated in a naturally occurring malignancy, namely the mam-
mary carcinomas associated with infection by mouse mam-
mary tumor virus (4, 35, 39). Here again the effects appear
to be transcriptional implying that it is the normal gene prod-
uct that contributes to neoplasia.
Cloning and sequence analysis of these independently iso-
lated genes showed that they encoded a product of -22 kD
that has significant homology to the fibroblast growth factor
(FGF) family (11, 47, 55). The prototypes for this family, the
so-called acidic and basic FGFs (aFGF and bFGF, respec-
tively), are broad spectrum mitogens that have been isolated
from a wide variety of tissues (8, 21, 41, 49) . Recently, how-
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cent cells, and the absence of glycosylation had no ap-
preciable effect on the transformation efficiency on
NIH3T3 cells. In contrast, mutants of kFGF that re-
main in the cytoplasm or are retained in the secretory
pathway, through addition of a KDEL motif, score
negative in standard transformation assays. Since
transformation by either the glycosylated or un-
glycosylated form of kFGF can be reversed by addi-
tion of suramin, the data imply that secretion of
kFGF, or surface localization of the ligand/receptor
complex, is a prerequisite for transformation.
ever, the classification of the FGFs has come to rely more
on sequence comparisons than on functional equivalence.
On this basis, the family also includes int-2, FGF-5, FGF-6,
and keratinocyte growth factor (KGF),I as well as kFGF (9,
13, 14, 17, 31, 43, 56). As the family has grown, it is the two
prototypic FGFs that now appear unusual in that they lack
typical signal sequences for passage through the ER, where-
as all the other FGF-related genes encode secreted proteins
(1, 12, 15, 17, 26, 31, 55, 56) . For example, the sequence of
human Kfgf predicts a hydrophobic amino terminus from
which the first 29 amino acids are removed during transit
through the secretory pathway (12, 47). A similar situation
prevails for mouseKfgfalthough there is some sequence vari-
ation at the presumed signal peptide cleavage site (7, 25).
Otherwise, the two proteins are 82% homologous and share
a single consensus site for asparagine-linked glycosylation .
Not surprisingly, kFGF can be readily detected in the
secretory pathway and conditioned medium of producing
cells, either immunologically or functionally as a heparin
binding mitogen (12, 32, 52). The protein is also reported
to induce phenotypic changes, analogous to transformation,
when added to cultured cells (11, 32) . Such findings suggest
that transformation requires interaction between the secreted
protein and specific cell surface receptors (48, 52). Similar
conclusions have been drawn from studies on bFGF where
the provision of a signal sequence appears to enhance its
transforming potential (6, 40, 54) . However, these analyses
did not exclude the possibility of intracellular interactions
1. Abbreviation used in this paper: KGF, keratinocyte growth factor.
547between the growth factor and high-affinity receptors, as
previously suggested for the product of the v-sis oncogene (5,
18, 23, 28) . We have addressed this issue more directly by
constructing mutant forms ofmouseKfVwhose products are
impaired for glycosylation, secretion or both . Although all
the mutant proteins retained biological activity, as judged by
their ability to induceDNA synthesis in quiescent cells, only
the secreted forms ofkFGF were able to induce morphologi-
cal transformation .
MaterialsandMethods
Construction ofMutant kFGFs
All of the kFGF mutants were based on a cDNA clone of mouse Kfgfpre-
pared using the polymerase chain reaction (PCR) with RNA from F9 ter-
atocarcinoma cells (7) . This clone contains one difference (valineto alanine
at 127) from the sequence of Hebert et al. (25) . The primers for the PCR
reaction were designed so that the coding sequences are bounded by Xbal
and EcoRI sites (Fig. 1), and the ATG that specifies the beginning of the
open reading frame is contained within a unique Ncol site. The sequences
immediately preceding the ATG conform to the consensus for translation
initiation (30) .
To construct the KDEL mutant, two complementary oligonucleotides
(5'-GTAACCCACTTCCTTCCTAGACTGAGCGAGAAGGACGAGCTGT
GATAAG-3' and 5'-AATTCTTATCACAGCTCGTCCTTCTCGCTCAGT
CTAGGAAGGAAGTGG-3) were used to replace the carboxy-terminal se-
quences, between unique BstEII and EcoRI sites . As well as the last eight
amino acids of mouse kFGF, these oligonucleotides encoded the SEKDEL
motif followed by two in frame stop codons (Fig . 1) . For the NSP mutant,
a primer was designed to place an in-frame initiation codon at the signal
peptide cleavage site . The 28-nucleotide primer, 20 nucleotides of which
were based on the mouse Kfgfsequence, was used as the 5'partner in a PCR
reaction in which the 3' primer was centered on a unique Sacl site in the
KfgfcDNA(Fig . 1) . The 265-bp Ncol-Sacl product was then used to replace
the corresponding sectionofwild-type cDNA, thereby excluding the amino-
terminal 77 by that specify the signal peptide of kFGF. As a result, the se-
quences immediately preceding the new ATG were identical to those in the
wild type construct, and optimized for initiation of translation . Finally, in
the GLY- mutant, the asparagine codon (AAC) at residue 32 was changed
to a glutaminecodon(CAG) usinga mutagenesis kit supplied by Amersham
International (UK .) . The complementary oligonucleotide used to generate
the mutation was 5'-GCGTGCCCTGGGGTGC-3' and the template was the
coding strand ofmouse KfgfcDNA in MI3mp19. The modified cDNA was
then recloned as a double stranded XbaI-EcoRI fragment in the pGEM4
vector (Promega Biotec, Madison, WI) . The relevant sections of each mu-
tant were subjected to DNA sequence analysis using specific oligonucleo-
tides to prime synthesis on the completed double-stranded plasmids.
The various mutant forms of Kfgf cDNA were initially constructed in
pGEM4 and transferred into the pKC4 vector (kindly provided byD. Hana-
han, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) as Xbal-
EcoRl fragments . The same fragments wereligated between the BamHI and
EcoRI sites ofthe pDOBS retrovirus vector (33) by filling in the Xbal and
BamHI cleavage sites with T4 DNA polymerase to create blunt ends .
Cellfree Transcription andTranslation
The pGEM4-based plasmids, containing wild-typeandmutant KfgfcDNAs,
were linearized with EcoRI and transcribed into senseRNA with T7 RNA
polymerase (Promega Biotec) in the presence ofm7GpppG (New England
Biolabs, Boston, MA), as recommended by PromegaBiotec . Approximately
1 leg of each transcript was used to direct protein synthesis in a rabbit
reticulocyte lysate (Promega Biotec) . To produce 35S-labeled products, the
reactions were carried out in the presence of 5 p,Ci of [BSS]methionine
(Amersham International) . Otherwise, reactionconditions wereas specified
by the supplier.
Thymidine Incorporation Assays
C57MG mammary epithelial cells (50) were grown in DMEM containing
10% newborn calf serum (Gibco Laboratories, Grand Island, NY) . For
mitogenicity assays, 5 x 10° cells were transferred to each well of a 24-
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Figure 1. Structures of wild type and mutant kFGFs. The 609-
nucleotide coding domain of mouse Kfgf is represented by the
shaded box in which the lighter shading depicts the amino-terminal
signal sequence . The signal peptide cleavage site (o) and the single
consensus for asparagine linked glycosylation (-Y-) are indicated,
but the diagram is not drawn to scale. ThecDNA product generated
by PCR is bounded by sites for Xbal and EcoRI, and there are
unique internal sites for Ncol (spanning theAUG codon), Sacl and
BstEH . The essential features of the KDEL, NSP, and GLY- mu-
tants are also illustrated . In the KDEL mutant, two complementary
oligonucleotides encoding the amino acids -Ser-Glu-Lys-Asp-Glu-
Leu- (SEKDEL) were used to replace the sequences between the
BstEII and EcoRl sites of Kfgf In the NSP mutant, synthetic oligo-
nucleotide primers (bold arrows) were used to amplify sequences
between the signal peptide cleavage site and the Sacl site, enabling
translational initiation at an ATG contained within a novel Ncol
site . This fragment was used to replace the corresponding section
of wild type KfgfcDNA . In the GLY- mutant, the Asn-32 codon
was changed to Gln, preventing carbohydrate addition .
well tissue culture plate in 500 g1 ofmedium . After 24 h, the medium was
replaced with DMEM containing 0.1% serum, and after a further 72 h the
cells were considered quiescent . The cells were then treated with samples
(2 or 10 til) ofthe various cell-free translation reactions in 500 pl of fresh
DMEM and 0.1% serum, for 16 h . The induction ofDNA synthesis was
assessed by labeling the cells with 5,uCi per well of [3H]thymidine (Amer-
sham International) for 3 h and measuring the incorporation of label into
acid-insoluble material . The cells were washed twice in PBS, fixed for 20
min in cold 5 % (wt/vol) trichloroacetic acid, allowed to dry and finally
lysed in 500 wl of a solution containing 1 M NaOH, 2% Na2C03, and
1% SDS. The amount of3H-labeled material in the acid precipitate was de-
termined by liquid scintillation counting. Each assay was performed in
duplicate .
Cell Transformation Assays
NIH3T3 cells, grown inDMEM plus 10% calf serum, were passaged 24 h
priorto transfectionwith the various KfgfcDNAs in theMuLVbased retro-
virus vector, pDOBS (33) . For each transfection, 106 cells in a 9-cm cul-
ture dish were exposed to 100 ng of plasmid DNA and 20 kg ofhuman pla-
cental DNA as a calcium phosphate precipitate (53) . After 24 h, the cells
were passaged at ratios of 1:3 and 1:30, and duplicate pools established of
each dilution. One group was placed inDMEM containing 10% calf serum
and G418 (Gibco Laboratories) at 500 wg/ml . Since the retrovirus vector
contained the neomycin resistance gene, all cells that take up and express
the inputDNA will acquire resistance to G418. These pools therefore pro-
vided ameasureoftransfection efficiency, and subsequently allowed the iso-
lation of individual colonies of transfected cells . The second group was
placed in DMEM containing 5 % calf serum, to promote the appearance
of transformed foci against a background ofnormal cells . The numbers of
foci and of G4181 colonies were counted at 10-12 d after transfection .
Electroporation ofCOS1 Cells
COS-1 monkey cells, constitutively expressing SV40 Tantigen (19), were
548cultured inDMEM supplemented with 10% FCS . The various KfgfcDNAs,
in the SV40-based vectorpKC4 (fromD. Hanahan) were introduced by elec-
troporation of 10 6 cells with 20 hg ofpurified plasmidDNA at 450 V/250
juF, using a Bio-Rad Gene Pulser (Bio-Rad Laboratories, Richmond, CA).
Cells were harvested -60 h later when transient expression of the input
DNA had reached a maximum .
Analysis ofkFGFProteins in Transfected Cells
Transfected NIH3T3 and COS-1 cells were labeled by addition of 500,UCi
of [35S]methionine and [35S]cysteine ("Express Labeling Mix" from New
England Nuclear) inDMEM (depleted of methionine and cysteine) and 2 %
dialyzed calf serum . After labeling for 4 h, the medium (1 .5 ml per 9-cm
dish) was recovered for further analysis and the cells were washed twice in
PBS . Total cell extracts were prepared by lysis in RIPA buffer, essentially
as described in Harlow and Lane (24) . The media and cell extracts were
immunoprecipitated with a polyclonal rabbit serum raised against the
carboxy-terminal 12 amino acids ofmouse kFGF Immune complexes were
recovered by association with protein A-Sepharose (Pharmacia Fine Chem-
icals) and separated by electrophoresis in 12 .5 % polyacrylamide gels in the
presence ofSDS (SDS-PAGE) according to standard procedures (24) . The
'IS-labeled products were detected by autoradiography .
Results
Construction ofkFGFMutants
Figure 2 . Cell-free translation ofkFGF proteins . The wild type and
mutant Kfgfsequences, in thepGEM4 vector, were transcribed into
sense RNA with T7 polymerase, and 1 Ag of each RNA was used
to direct protein synthesis in a reticulocyte lysate . Products labeled
by incorporation of [35S]methionine were fractionated by elec-
trophoresis in a 12 .5% polyacrylamide gel and visualized by auto-
radiography. The various Kfgf constructs are as indicated, and
-RNA signifies a control reaction in which no RNA was added .
Numbers on the left refer to the sizes, in kilodaltons of the protein
markers (Amersham International) .
Modified forms ofmouse KfgfcDNA (7) were constructed
so that the encoded products would be impaired for secretion
or glycosylation (Fig . 1) . In the first of these, the carboxy-
terminus of the protein was modified to include the Ser-Glu-
Lys-Asp-Glu-Leu (SEKDEL) motif that has been shown to
cause retention of proteins in the ER (34, 38) . Since the sig-
nal sequence was left intact, this product would be expected
to enter but effectively remain in the secretory pathway. In
theNSP mutant, on the other hand, the hydrophobic amino
terminus was removed so that the translation product would
no longer pass,into the ER (Fig . 1) . The NSP form ofkFGF
would therefore be expected to reside in the cytoplasm . In
the third mutant, designated GLY- , the asparagine-32 co-
don ofmousekFGF was changed to a glutamine codon . This
point mutation removed the Asn-X-Ser/Thr target for car-
bohydrate addition but left the remainder of the protein un-
changed . Details of these modifications are presented in
Materials and Methods .
Each ofthe mutatedcDNAs was inserted into three differ-
ent vectors to facilitate various functional assays . For cell-
free translation, the cDNAs were cloned into the pGEM4
plasmid to permit transcription of sense RNA with T7RNA
polymerase ; for transient expression in COS célls, the con-
structs were based on the pKC4 vector carrying the SV40
early promoter (15) ; and for the transformation assays in
NIH3T3 cells, we used a retrovirus-based vector carrying an
independently expressed neomycin-resistance gene (20) .
Transformation ofNIH3T3 CellsbyMutantkFGFs
Mitogenic Activity ofkFGFMutants
As we had previously shown that synthetic kFGF, produced
by cell-free translation, is capableofinducing DNA synthesis
in serum-deprived cells (15), we first wanted to confirm that
the various mutant kFGFs had retained full activity in this
assay. In vitro translation reactions were therefore performed
in rabbit reticulocyte lysates programmed with 1 hg ofsense
transcript from each of the cDNAs . The incorporation of
[35S]methionine allowed both qualitative and quantitative
comparison of the products by electrophoresis in SDS-
polyacrylamide gels. As shown in Fig. 2, the mutant proteins
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were of the predicted sizes and the translation efficiencies
were similar for all the constructs . To assess their mitogenic
properties, unlabeled products from parallel translation re-
actions were used in thymidine incorporation assays .
C57MG mouse mammary epithelial cells (50) were ren-
dered quiescent by reducing the serum concentration to
0.1% . Samples of each translation reaction were then added
to the cells, inmedium containing 0.1% serum, and 16 h later
the effects on DNA synthesis were assessed by measuring the
incorporation of [3H]thymidine into acid insoluble material
(see Materials and Methods) . As shown in Fig . 3, the mutant
kFGFs were all capable of inducing DNA synthesis in these
cells . With 10 pl samples of each lysate, the incorporation
of [ 3H]thymidine was close to the maximum achieved by
addition of 10% serum . The assay was therefore repeated
using an amount of lysate (2 ul) that gave an approximately
half-maximal response with the wild-type kFGF . Within the
limits of such an assay, each of the mutant kFGFs elicited
comparable mitogenic responses (Fig . 3) .
We next wished to determine whether the various mutants
also had comparable transforming activities . To this end, the
differentcDNAs were ligated into an MuLVbased retrovirus
vector to ensure efficient expression in mouse cells. The
plasmid DNAs were then introduced into NIH3T3 cells as
calcium phosphate precipitates and the transfected cells
scored for focus formation after 10-12 d . Since the vector
also encoded the neomycin-resistance gene, the efficiency of
transfection could be monitored by counting the numbers of
colonies that acquired resistance to the drug G418 (see
Materials and Methods) .
549Figure 3 . Induction of DNA synthesis by synthetic kFGFs . The
products of cell-free translation reactions, performed as in Fig. 2
but without [35S]methionine, were added to quiescent C57MG
cells, and the effects on DNA synthesis assessed after 16 h . The
histograms indicate the incorporation of [3H]thymidine into acid-
insoluble material in response to either 2 td (lighter shading) or 10
1tl (darker shading) of reticulocyte lysate in a total of 500 ul of
medium with 0.1 % serum. The different Kfgfconstructs are as indi-
cated, with -RNA referring to the background level of incorpora-
tion observed with the reticulocyte lysate alone. The addition of
10% serum was used as a measure of the maximum response .
As illustrated in Fig . 4, and quantitated in Table I, both
the wild-type and GLY- mutants induced numerous foci of
transformed cells, whereas no foci were detected with the
KDEL and NSP mutants, or with the vector alone . The
transfection efficiencies, as measured by numbers ofG418R
colonies, were roughly the same for each DNA, although in
this experiment the GLY- yielded fewer colonies (Table I) .
Nevertheless, the transforming efficiency oftheGLY- DNA,
as reflected in the percentage of G418R colonies that ap-
peared morphologically transformed, was indistinguishable
from that of wild-typekFGF . These transformed cells were
also similar in their ability to grow as anchorage-indepen-
dent colonies in soft agar (not shown) . In contrast, the
G418R colonies obtained with the KDEL and NSP mutants
appeared morphologically normal and did not grow in soft
agar (not shown) .
Expression ofMutantkFGFs in NIH3T3 Cells
As the mutant forms ofkFGF were designed to have altered
subcellular fates, it was essential to confirm that the differ-
ences in transforming efficiencies were attributable to differ-
ences in the processing and/or secretion of the products.
Pools ofG418R NIH3T3 cells, transfected with the various
constructs, were labeled with [31S]methionine and cysteine
and the culture media and total cell extracts recovered for
analysis . After immunoprecipitation, using a rabbit poly-
clonal antiserum raised against a COOH-terminal peptide
from mouse kFGF, the labeled proteins were fractionated by
polyacrylamide gel electrophoresis and visualized by autora-
diography (Fig. 5) . We confirmed that this antibody recog-
nized wild-type and mutant kFGFs with similar efficiency, as
judged by inununoprecipitation of [35S]methionine-labeled
in vitro translation products (not shown) . The wild-type and
GLY- products were detectable in both the cells and medi-
um, as expected for secreted proteins . The major difference
noted for the GLY- mutant was in the smaller size of the
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Figure 4 . Transformation of NIH3T3 cells byKWDNA . NIH3T3
cells were transfected with thewild-typeand mutantKfgfconstructs
in thepDOBS vector, as described in Materials and Methods, and
stained with Giemsa after 12 d . Multiple foci were discernible with
the wild type and GLY- mutant, as indicated, but not with the
KDEL and NSP mutant cDNAs, or with the vector alone .
protein, which reflected the absenceofglycosylation . In con-
trast, the slightly larger KDEL mutant was apparently glyco-
sylated, but could not be detected in the medium, despite
relatively high intracellular levels (Fig . 5) . This wouldbecon-
Table I. Transformation Efficiency ofKfgfcDNAs
* Transformation efficiency was calculated as number of foci/number of
G4181 colonies .
550
Plasmid
G4181 colonies
per lAg DNA
Foci
per jig DNA
Transformation
efficiency*
pDOBS 2,625 0 -
WT 2,170 2080 0.96
KDEL 2,580 0 -
NSP 2,280 0 -
GLY- 1,430 1350 0 .94Figure 5. Expression ofkFGF proteins in NIH3T3 cells . Pools of
G418R NIH3T3 cells transfected with the indicated cDNAs in the
pDOBS vector were metabolically labeled with [35S]methionine
and cysteine and the cell extracts (left) and conditioned media
(right) were immunoprecipitated with an antiserum against the car-
boxy terminus ofmousekFGR The immunoprecipitates were frac-
tionatedby SDS-PAGE in a 12.5% gel and the labeledproteins were
visualized by autoradiography . Equivalent amounts of the extracts
and media were analyzed and the expected kFGF products are
identified by * . The sizes (kilodaltons) of '°C-labeled protein
standards (Amersham International) are shown on the left .
sistent with retention within the ER . With the NSP mutant,
which was expected to be entirely cytosolic, it proved diffi-
cult to detect the protein in either fraction, possibly reflecting
a reduced stability in the cytoplasm as opposed to the ER
(Fig . 5) . In the wild-type and GLY- mutant, immunoreac-
tive proteins of a smaller size were seen in the medium ; these
appear to be degradation products of kFGF.
Expression ofMutantkFGFs in COS1 Cells
To compare the processing and stability of the mutant
kFGFs, we chose to use the COS cell system where it is pos-
sible to achieve high levels of expression using an SV40-
based vector (19) . The various cDNAs, in the pKC4 vector
(2, 15), were introduced into COS-1 cells by electroporation
and -60 h later, when levels of expression had reached their
peak, the cells were labeled with a 2-h pulse of ["S]methio-
nine and ["Slcysteine. As shown in Fig . 6, the wild-type
kFGF, and the KDEL and GLY- mutant proteins were
readily detectable, and at comparable levels . However, with
the NSP mutant, where the block to secretion was likely to
be much tighter, the intracellular levels were again low as
compared to the other mutants . This was not a function of
transfection efficiency since immunofluorescence assays con-
firmed that a similar proportion of transfected cells were ex-
pressing the kFGF products in each case (not shown) . Thus,
the cytoplasmic form encoded by the NSP mutant appeared
inherently less stable or was less efficiently expressed in both
COS-1 and NIH3T3 . Pulse-chase experiments (not shown)
indicated that the half-life of the NSP protein in COS-1 cells
is -40 min, compared to -100min for the wild-type kFGF,
but it is not clear whether this twofold difference is enough to
account for the low levels of NSP protein observed .
Transformation Can Occur via an Autocrine Loop
The data shown above imply that the ability of kFGF to
transform NIH3T3 cells could be abrogated by mutations
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Figure 6. Expression ofkFGF proteins in COS-1 cells . The various
KfgfcDNAs in the pKC4 vector, as well as the vector alone as a
control, were introduced into COS-1 cells by electroporation . After
60 h, the cells were labeled with ["Slmethionine and cysteine and
the kFGF-related proteins in the cell extracts were analyzed by im-
munoprecipitation and SDS-PAGE, as in Fig . 5. The positions and
sizes (kilodaltons) of°C-labeled proteins markers (Amersham In-
ternational) are indicated on the left .
that impaired the secretion of the protein . However, we felt
it necessary to confirm that the secreted forms of the protein
were indeed active, and that no functional protein was being
released from the KDEL and NSP expressing cells, at levels
below the sensitivity of the immunological assay. Since the
medium from normal NIH3T3 cells was found to contain
significant mitogenic activity on the C57MG indicator cells,
irrespective of transfection by the various kFGFs, the most
direct functional test was whether the protein itself could
elicit transformation . Conditionedmedium taken from pools
of transfected NIH3T3 cells, grown for 24 h in the absence
of G418, was added to fresh cultures ofNIH3T3 cells, and
their morphology assessed after a further 16-20 h . As shown
in Fig . 7, the media containing either wild-typekFGF or the
GLY- mutant were able to cause dramatic changes in mor-
phology, whereas media from untransfected NIH3T3 cells or
from cells expressing the KDEL and NSP mutants did not .
The phenotype was evenmore pronounced ifheparin was in-
cluded in the conditioned medium . These morphological re-
sponses to exogenous kFGF were transient in that removal
of the conditioned medium allowed the cells to revert to a
normal phenotype. In the converse experiment, we asked
whether the polyanionic compound suramin, which has been
shown to dissociate some growth factors from their cognate
receptors, was able to block transformation . Addition of
1 mM suramin for 16 h was sufficient to revert the phenotype
of transfected cells expressing either wild-type or GLY-
kFGF (Fig . 8) . Since these cells are constitutively expressing
kFGF, morphological transformation was reestablishedwhen
the suramin was removed (not shown) . Neither heparin nor
55 1Figure 7 . Transformation of NIH3T3 cells by con-
ditioned medium from cells expressing kFGF. The
media recovered from pools of NIH3T3 cells ex-
pressing wild type kFGF, the GLY- mutant or
from untransfected cells, were clarified by cen-
trifugation and added to fresh cultures of NIH3T3
cells in the presence or absence of heparin at 50
jug/ml (Sigma Chemical Co.) . The cells were pho-
tographed under phase contrast 16hafter addition
of the medium . Bar, 25 Am .
Figure 8. Reversal of Kfgf-induced transformation by suramin . NIH3T3 cells transformed by either wild-type Kfgfin the pDOBS vector
or by human K-ras DNA were grown for 24 h in the presence or absence of 1 mM suramin . The cells were then photographed under
phase contrast . Suramin caused morphological reversion of the kFGF-expressing cells but had no discernible effect on the K-ras control
cells . Bar, 25 /Am .
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552suramin had any effect on the normal appearance of NIH3T3
cells transfected with the KDEL or NSP mutants, or on the
phenotype of cells transformed by K-ras DNA (Fig. 8).
Discussion
The notion that autocrine stimulation of cell growth can play
a significant role in tumorigenesis has gained considerable
support from the fact that certain oncogenes, implicated in
experimental and naturally occurring cancers, encode growth
factors or products related to growth factors. The classic ex-
ample is the relationship between the v-sisoncogene and the
B-chain of PDGF (16, 51), but subsequent examples have
mostly involved members of the FGF family. Thus, the genes
for int-2, kFGF, FGF-5, and FGF-6 can all be classed as on-
cogenes because they are capable ofinducing morphological
transformation of NIH3T3 cells (11, 20, 31, 47, 56), and both
int-2 and Kfgfhave been implicated in virally induced mam-
mary tumors in mice (14, 39). The point at issue is whether
transformation as a result of autocrine stimulation is depen-
dent on interactions between ligand and receptor at the cell
surface, or whether intracellular encountersbetween the two
can also complete the autocrine loop. Here we present evi-
dence that for kFGF, the former situation prevails.
Our approach was to construct mutant forms of kFGF that
differed in post-translational processing and subcellular fate
but retained intrinsic mitogenic activity. The three mutants
compared here were indistinguishable from the wild type
kFGF in their ability to induce DNA synthesis in quiescent
C57MG cells (Fig. 3), suggesting that the addition or loss
of residues at the carboxy or amino termini had little
influence on the function ofthe protein . However, the experi-
ments presented in Figs. 2 and 3 relied on products that were
neither cleaved nor glycosylated since they were translated
in the absence of microsomes. It was therefore important to
determine whether the wild type kFGF and the GLY- mu-
tant expressed in cells were also functionally equivalent,
particularly in view of reports that inhibition of glycosylation
by tunicamycin can impair secretion of kFGF (12) . In the
pools of transfected NIH3T3 cells, we observed only mar-
ginal differences between the secretion of the wild type and
GLY- forms (Fig. 5); otherwise the two products were
functionally indistinguishable. For example, the two cDNAs
were able to transform NIH3T3 cells with similar efficiency
(Fig. 4 and Table I), the two pools of transformed cells be-
haved identically in colony assays in soft agar (not shown),
and the conditioned media from these cells were equally
capable of eliciting morphological transformation of un-
transfected NIH3T3 cells (Fig. 7) . With COS-1 cells, on the
other hand, a much smaller proportion of the GLY- protein
appeared in the conditioned medium (not shown), suggesting
that the impairment to secretion may be a feature ofthe COS
cell system. We have previously noted striking differences
between the secretion of the int-2 protein from NIH3T3 and
COS-1 cells (unpublished results ; 15, 20).
The ability of Kfgf-conditioned medium to directly influ-
ence cellular morphology (Fig. 7) provides compelling evi-
dence that transformation of NIH3T3 cells can be mediated
by extracellular kFGF (11, 48). That the transformed pheno-
type can be enhanced by low concentrations of heparin and
essentially reversed by suramin (Fig. 8) lends further sup-
port, yet these data do not prove that an extracellular loop
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is essential for transformation. For example, secreted growth
factors have to traverse the same intracellular compartments
as their cognate transmembrane receptors, and it remains
possible that interactions leading to autocrine stimulation
might occur within the cell, without the need to externalize
the receptor/ligand complex. This was first suggested for
PDGF/sis, where retention in the ER through the addition of
KDEL sequences had little effect on the transforming prop-
erties (5, 28). However, it now appears that surface localiza-
tion of the receptor may be required to trigger the appropri-
ate signal transduction pathways (18, 23) .
With kFGF, addition of the KDEL motifto the carboxy
terminus blocked both the release of immunologically de-
tectable protein into the medium (Fig. 5) and the capacity
to transform NIH3T3 cells (Fig. 4 and Table I). Otherwise,
the rate ofsynthesis, intracellular stability and mitogenic ac-
tivity ofthe protein appeared unimpaired, although it is con-
ceivable that the presence of the KDEL motif had subtle
effects that were not apparent in the experiments wedescribe.
For example, the glycosylated protein expressed in trans-
fected cells may be a less effective ligand than the un-
processed form synthesized in vitro. However, after ex-
tended periods in culture, the morphologies of some of the
NIH3T3 colonies transfected with the KDEL mutant began
to resemble those of transformed cells. We attribute this to
the selection ofclones expressing high levels of intracellular
kFGF, allowing the release of enough extracellular protein
to effect transformation. Immunoprecipitation analyses con-
firmed that these partially transformed colonies contained
elevated levels of intracellular kFGF compared with their
nontransformed counterparts (not shown) . During the prepa-
ration of this manuscript, Tàlarico and Basilico reported
similar observations using a modified form of human kFGF
bearing theKDELmotif(48) . Intheir studies, sporadic trans-
formation also correlated with high expression ofthe protein
and was partially reversible with neutralizing anti-kFGF se-
rum, consistent with an extracellular interaction between the
ligand and receptor.
As anticipated, we did not observe transformation with the
NSP mutant of mouse kFGF (Fig. 4 and Table I) since the
protein remains largely cytosolic and should not encounter
receptors within the cell. In this regard, the NSP form
resembles aFGF and bFGR Although these factors are
reputed to induce morphological changes when added to
cells(22, 49), neither gene scores positive in a conventional
focus assay unless provided with a signal sequence for secre-
tion of the protein (6, 42) . However, there are also indica-
tions that overexpression may elicit transformation, possibly
through paracrine effects by factors released from damaged
or dying cells (27, 37, 40, 46) . In the experiments we report
here, the intracellular levels of NSP mutant were relatively
low (Figs. 5 and 6), so that leakage into the extracellular
compartment may never have reached the threshold needed
for transformation.
The studies reported here support the findings of Tàlarico
and Basilico (48) and clearly imply that to initiate signal
transduction, the interaction between kFGF and its receptor
must occurat the cell surface. This does not rule out associa-
tion between ligand and receptor in an intracellular compart-
ment, but suggests that such interactions are only productive
when localized at the plasma membrane. The threshold of
extracellular ligand needed for autocrine stimulation and
553transformation will naturally depend on its affinity for the
receptor(s) . Sinceit is now clear that there is a family of FGF
receptors, and that each may be expressed as alternative iso-
forms, the phenotype of a cell expressing kFGF, or the mu-
tant kFGFs described here, will depend on the integrated re-
sponse to multiple receptor-ligand interactions. Dissection
of these events will be an obvious focus of future research .
We thank Peter Parker, John Armstrong, David MacAllan, and Gerard
Evan for critical reading of the manuscript and Bayer AG for providing
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